Lv12
28 积分 2025-08-27 加入
Disease modification in inflammatory skin disorders: opportunities and challenges
29分钟前
待确认
Improvement of Pruritus and Efficacy in the Early Stage of Therapy with Upadacitinib, Abrocitinib, or Dupilumab in Chinese Patients with Moderate-to-Severe Atopic Dermatitis: Prospective, Cohort, Observational Study
1天前
已完结
Outcomes of Down-Titration in Patients with Severe Scalp Alopecia Areata Initially Treated with Baricitinib 4-mg: Week 152 data from BRAVE-AA2
6天前
已完结
Ritlecitinib for severe alopecia areata in children under 12 years: A retrospective review of 18 cases
7天前
已完结
The safety of systemic Janus kinase inhibitors in atopic dermatitis: A systematic review and meta‐analysis of randomized controlled trials
7天前
已完结
Use of ritlecitinib in patients with alopecia areata refractory to tofacitinib or baricitinib: A single-center retrospective cohort study
8天前
已完结
Evaluating the Early Efficacy and Safety of Ritlecitinib in Moderate Alopecia Areata: A Real-World, Single-Center Study
8天前
已完结
Ritlecitinib in clinical practice: a real-world study of efficacy, safety and prior Janus kinase inhibitor impact in alopecia areata
8天前
已完结
Real-world assessment of ritlecitinib in patients with severe alopecia areata: a 24-week multicentre retrospective study
8天前
已完结
Real‐life effectiveness and safety of baricitinib in adults with alopecia areata: A multicentre study
8天前
已完结
[Para-Bombay phenotype due to bi-allelic heterozygous base deletions of FUT1 gene]
皖公网安备34019202002308
